Jaikanth Chandrasekaran

11PUBLICATIONS
32CO-AUTHORS
Biomolecular modelling and designBiologically active moleculesMolecular targetsMolecular medicineImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Mar 21, 2026
Ligand and Structure-Based Drug Design of Biphenyl 1,2,4-Triazole Derivatives as Dual Target Inhibitors of Aromatase and Steroidal Sulfatase as Anti-Breast Cancer Agents.

G Vivekananthan, Varun Sankar Siva Subramaniam, N J Sai Sruthi

|Mar 02, 2026
Nature meets machine: the AI renaissance in natural product drug discovery.

Rajesh Muthuraj, Jaikanth Chandrasekaran

|Oct 19, 2025
Integrated computational-experimental pipeline for CHK1 inhibitor discovery: structure-based identification of novel chemotypes with anticancer activity.

Dhanushya Gopal, Manasa Pacharla, Nehal Arvind Kumar

|Mar 19, 2025
Integrated AI and machine learning pipeline identifies novel WEE1 kinase inhibitors for targeted cancer therapy.

Jaikanth Chandrasekaran, Dhanushya Gopal, Lokesh Vishwa Sureshkumar

|Feb 28, 2024
Computational discovery of novel FYN kinase inhibitors: a cheminformatics and machine learning-driven approach to targeted cancer and neurodegenerative therapy.

Dhanushya Gopal, Rajesh Muthuraj, Rex Devasahayam Arokia Balaya

|Jan 19, 2024
Insightful t-SNE guided exploration spotlighting Palbociclib and Ribociclib analogues as novel WEE1 kinase inhibitory candidates.

Rajesh Muthuraj, Dhanushya Gopal, Iqrar Ahmed

Pageof 2

Frequent Collaborators

2 joint publications

Rajesh Muthuraj

2 joint publications

Iqrar Ahmed

2 joint publications

T S Keshava Prasad

2 joint publications

Rex Devasahayam Arokia Balaya